INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Man accused of beating mother unconscious
A Muncie man is accused of attacking his own mother after she suggested he get a job.
Block Burners gang members arrested in Kentucky
Two members of the Block Burners gang targeted by the FBI last week were arrested Tuesday night in Kentucky.
Driver in fatal bus crash had suspended license
A 6-year-old boy was killed and several others were injured in a church bus crash on Interstate 70 on Tuesday afternoon.
CALL 6: Floorboard rust problem irks drivers
Call 6 Investigates has uncovered a problem that could be lurking right under your feet, and some car owners are demanding action.
Mayor: Connersville out of financial emergency
The mayor of cash-strapped Connersville said the city has emerged from an extended period of belt tightening.